Bath & Body Works logged a -0.12% change during today's afternoon session, and is now trading at a price of $42.37 per share. The S&P 500 index moved 0.63% and the Nasdaq posted a 1.02% change.
Bath & Body Works shares moved -20.53% over the last 52 weeks, with a high of $56.96 and a low of $25.34. During this time, the stock lagged the S&P 500 index by -11.3%. As of January 2022, the company's 50-day average price is $44.05. None. The mid-cap Consumer Cyclical company is based in Columbus, OH. Bath & Body Works has returned a 1.84% dividend yield over the last 12 months.
Exceptional EPS Growth Obtained Primarily Through Share Buybacks:
|Gross Margins Growth||n/a||-49.9%||42.72%||93.76%|
|Operating Margins Growth||n/a||-13.51%||69.71%||94.9%|
|Earnings Per Share||$2.34||-$1.32||$3.04||$5.25|
|Free Cash Flow (MM)||$748||$778||$1,811||$1,222|
|Capital Expenditures (MM)||$629||$458||$228||$270|
|Net Debt / EBITDA||2.4||5.16||1.65||1.25|
Bath & Body Works Is Fairly Priced at Current Levels:
Compared to the Consumer Cyclical sector's average of 22.33, Bath & Body Works has a trailing twelve month P/E ratio of 12.46 and, according to its EPS guidance of 4.07, an expected P/E ratio of None.
Bath & Body Works's elevated P/B ratio notwithstanding, the company's strong cash flows, decent earnings multiple, and healthy debt levels factor towards it being fairly valued.
18 analysts are following Bath & Body Works and have set target prices ranging from $40.0 to $76.0 per share. On average, they have given the company a rating of buy. At the current price of $42.37, BBWI is trading -18.25% away from its average analyst target price of $51.83 per share, implying an analyst consensus of some upside potential for the stock.